Fusion Antibodies plc (AIM:FAB)

London · Delayed Price · Currency is GBP · Price in GBX

13.55

-0.45 (-3.21%)

Apr 15, 2026, 4:06 PM GMT

Revenue by Segment

Financials in millions GBP. Fiscal year is April - March.

Millions GBP. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Research, Development and Manufacture of Recombinant Proteins and Antibodies	1.97M	1.14M	2.90M	4.80M	4.17M
Research, Development and Manufacture of Recombinant Proteins and Antibodies Growth	72.98%	-60.84%	-39.55%	15.22%	6.93%
Total	1.97M	1.14M	2.90M	4.80M	4.17M
Total Growth	72.98%	-60.84%	-39.55%	15.22%	6.93%

Revenue by Geography

Financials in millions GBP. Fiscal year is April - March.

Millions GBP. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
United Kingdom	569.00K	195.00K	621.00K	724.00K	711.00K
United Kingdom Growth	191.79%	-68.60%	-14.23%	1.83%	26.74%
Rest of Europe	101.00K	95.00K	409.00K	1.39M	1.13M
Rest of Europe Growth	6.32%	-76.77%	-70.66%	23.91%	-9.71%
North America and Rest Of World	1.30M	846.00K	1.87M	-	-
North America and Rest Of World Growth	53.07%	-54.78%	-	-	-
North America	-	-	-	2.00M	1.71M
North America Growth	-	-	-	16.69%	19.44%
Rest of World	-	-	-	681.00K	615.00K
Rest of World Growth	-	-	-	10.73%	-5.82%
Total	1.97M	1.14M	2.90M	4.80M	4.17M
Total Growth	72.98%	-60.84%	-39.55%	15.22%	6.93%

Source: S&P Global Market Intelligence.